20 June 2013
Keywords: pylori, vaccine, sparks, speculation, ulcer, market, news
Article | 14 October 1996
The news that OraVax will present promising immunogenicity data from a
Phase II study of its Helicobacter pylori vaccine in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 October 1996
21 October 1996
19 June 2013
© 2013 thepharmaletter.com